Clinical Trial Update: P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of p53 gene therapy with radiotherapy and chemotherapy for unresectable locally advanced head and neck ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Gendicine (recombinant adenovirus p53 gene therapy)

Snippet

Sponsor: Shenzhen SiBiono GeneTech Co.,Ltd | Conditions: Advanced Head and Neck Cancer | Phase 2 | Status: UNKNOWN